![James New](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James New
Amministratore Delegato presso Wavodyne Therapeutics, Inc.
Posizioni attive di James New
Società | Posizione | Inizio | Fine |
---|---|---|---|
Wavodyne Therapeutics, Inc.
![]() Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY. | Amministratore Delegato | - | - |
Presidente | - | - | |
Fondatore | - | - |
Storia della carriera di James New
Precedenti posizioni note di James New
Società | Posizione | Inizio | Fine |
---|---|---|---|
NEUROTROPE, INC. | Direttore/Membro del Consiglio | 23/08/2013 | 05/08/2014 |
Amministratore Delegato | 23/08/2013 | 16/07/2014 | |
Presidente | 23/08/2013 | 16/07/2014 | |
SYNAPTOGENIX, INC. | Amministratore Delegato | - | 16/07/2014 |
Presidente | - | 16/07/2014 | |
VELOXIS PHARMACEUTICALS A/S | Amministratore Delegato | 27/11/2008 | 01/01/2009 |
Presidente | 27/11/2008 | - | |
Abrika Pharmaceuticals LLP
![]() Abrika Pharmaceuticals LLP Pharmaceuticals: MajorHealth Technology Abrika Pharmaceuticals, Inc. develops and manufactures generic pharmaceuticals. The firm engages in the formulation and commercialization of both controlled release and immediate release products. The company was founded by Alan Phillip Cohen in May 2002 and is headquartered in Sunrise, FL. | Amministratore Delegato | 01/01/2002 | 01/01/2007 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/1999 | - |
PFIZER, INC. | Corporate Officer/Principal | 01/01/1994 | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1988 | - |
AIKO Biotechnology, Inc.
![]() AIKO Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services AIKO Biotechnology, Inc. provides commercial physical research solutions and services. It offers treatment for pain and the side effects associated with prescription pain reliever (opioid) use, such as opioid-induced bowel dysfunction, addiction, and abuse. The company was founded in 2006 and is headquartered in Portland, ME. | Amministratore Delegato | 20/09/2010 | - |
░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di James New
University of Maine | Graduate Degree |
State University of New York College at Geneseo | Undergraduate Degree |
State University of New York at Buffalo | Doctorate Degree |
Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Svizzera | 2 |
Regno Unito | 2 |
Posizioni
Chief Executive Officer | 6 |
Corporate Officer/Principal | 4 |
President | 3 |
Settori
Health Technology | 10 |
Consumer Services | 5 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
NOVARTIS AG | Health Technology |
PFIZER, INC. | Health Technology |
GSK PLC | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
SYNAPTOGENIX, INC. | Health Technology |
Aziende private | 5 |
---|---|
Abrika Pharmaceuticals LLP
![]() Abrika Pharmaceuticals LLP Pharmaceuticals: MajorHealth Technology Abrika Pharmaceuticals, Inc. develops and manufactures generic pharmaceuticals. The firm engages in the formulation and commercialization of both controlled release and immediate release products. The company was founded by Alan Phillip Cohen in May 2002 and is headquartered in Sunrise, FL. | Health Technology |
Veloxis Pharmaceuticals A/S
![]() Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
AIKO Biotechnology, Inc.
![]() AIKO Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services AIKO Biotechnology, Inc. provides commercial physical research solutions and services. It offers treatment for pain and the side effects associated with prescription pain reliever (opioid) use, such as opioid-induced bowel dysfunction, addiction, and abuse. The company was founded in 2006 and is headquartered in Portland, ME. | Commercial Services |
Neurotrope, Inc.
![]() Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Wavodyne Therapeutics, Inc.
![]() Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY. | Health Technology |
- Borsa valori
- Insiders
- James New
- Esperienza